The specificity of the commercial anti-EXO70 antibody was firstly verified by western blot and immunohistochemistry (IHC) in EXO70 knocking-down (KD) colon cancer cells (Supplementary Fig. S1a,b). This evidence concerns the gene EXOC7 and colonic neoplasm.